BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2616981)

  • 1. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
    Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
    Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of tumor markers in digestive oncology].
    Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C
    Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the measurement of serum carcinoembryonic antigen (CEA) levels using monoclonal antibody].
    Yoneshima M; Sawabu N; Kidani H; Takemori Y; Toya D; Okai T; Hattori N; Ogino T; Mai M
    Gan No Rinsho; 1985 Aug; 31(10):1311-7. PubMed ID: 4057566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of the determination of CA 19-9 in the follow-up of patients with gastroenteric neoplasms in comparison to CEA].
    Pecchio F; Piantino P; Oliaro A; Rapellino M; Ricci E; Aimo G; Obert R
    Minerva Med; 1986 Nov; 77(42-43):1973-81. PubMed ID: 3464850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen fraction in digestive cancer.
    Fong S; García Vega G; León V
    Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of serum TAC-41 in various digestive cancers].
    Sato S; Yamanaka T; Kimura K
    Rinsho Byori; 1989 Nov; 37(11):1259-62. PubMed ID: 2601083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours.
    Eskelinen M; Tikanoja S; Valkamo E; Loikkanen M; Collan Y
    Scand J Clin Lab Invest; 1988 Nov; 48(7):653-8. PubMed ID: 3201097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood levels of CA-50, CA-19.9, CA-125, enolase, CA-15.3 and carcinoembryonic antigen in non-cancerous bronchopulmonary pathology].
    Berthiot G; Marechal F; Deltour G
    Rev Mal Respir; 1988; 5(6):573-6. PubMed ID: 3217589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization and detection of cancer-associated antigens in patients with gastric cancer].
    Yuan M
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):457-61, 509. PubMed ID: 7509252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of fecal detection of cancer-associated antigens using monoclonal antibodies in the diagnosis of colorectal cancer].
    Yuan M
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):497-500, 511-2. PubMed ID: 2086118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.